ArticleBlood science (Baltimore, Md.)2026

LPCAT3 is essential for leukemia progression and represents a therapeutic vulnerability in AML.

Mutian Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.